» Articles » PMID: 32347316

Hepatitis B Virus X Protein Promotes Liver Cell Pyroptosis Under Oxidative Stress Through NLRP3 Inflammasome Activation

Overview
Journal Inflamm Res
Date 2020 Apr 30
PMID 32347316
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Hepatitis B virus X protein (HBx) is a pivotal factor for HBV-induced hepatitis. Herein, we sought to investigate HBx-mediated NLR pyrin domain containing 3 (NLRP3) inflammasome activation and pyroptosis under oxidative stress.

Methods: The effect of HBx on the NLRP3 inflammasome was analyzed by enzyme-linked immunosorbent assays, quantitative reverse transcription-polymerase chain reaction, western blotting, and immunofluorescence in hepatic HL7702 cells. Pyroptosis was evaluated by western blotting, lactate dehydrogenase release, propidium iodide staining, and transmission electron microscopy. NLRP3 expression in the inflammasome from liver tissues was assessed by immunohistochemistry.

Results: In hydrogen peroxide (HO)-stimulated HL7702 cells, HBx triggered the release of pro-inflammatory mediators apoptosis-associated speck-like protein containing a CARD (ASC), interleukin (IL)-1β, IL-18, and high-mobility group box 1 (HMGB1); activated NLRP3; and initiated pro-inflammatory cell death (pyroptosis). HBx localized to the mitochondria, where it induced mitochondrial damage and production of mitochondrial reactive oxygen species (mitoROS). Treatment of HL7702 cells with a mitoROS scavenger attenuated HBx-induced NLRP3 activation and pyroptosis. Expression levels of NLRP3, ASC, and IL-1β in liver tissues from patients were positively correlated with HBV DNA concentration.

Conclusions: The NLRP3 inflammasome was activated by elevated mitoROS levels and mediated HBx-induced liver inflammation and hepatocellular pyroptosis under HO-stress conditions.

Citing Articles

Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches.

Chatzikalil E, Arvanitakis K, Kalopitas G, Florentin M, Germanidis G, Koufakis T Cancers (Basel). 2025; 17(3).

PMID: 39941760 PMC: 11815926. DOI: 10.3390/cancers17030392.


Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives.

Yang S, Zou Y, Zhong C, Zhou Z, Peng X, Tang C Front Cell Dev Biol. 2025; 13:1522206.

PMID: 39917567 PMC: 11798966. DOI: 10.3389/fcell.2025.1522206.


Endothelial Dysfunction and Liver Cirrhosis: Unraveling of a Complex Relationship.

Nesci A, Ruggieri V, Manilla V, Spinelli I, Santoro L, Di Giorgio A Int J Mol Sci. 2024; 25(23).

PMID: 39684569 PMC: 11640898. DOI: 10.3390/ijms252312859.


Emerging Roles of High-mobility Group Box-1 in Liver Disease.

Wang L, Dong Z, Zhang Y, Peng L J Clin Transl Hepatol. 2024; 12(12):1043-1056.

PMID: 39649031 PMC: 11622203. DOI: 10.14218/JCTH.2024.00317.


Unveiling the nexus: pyroptosis and its crucial implications in liver diseases.

Miao Z, Zhang X, Xu Y, Liu Y, Yang Q Mol Cell Biochem. 2024; .

PMID: 39477911 DOI: 10.1007/s11010-024-05147-1.


References
1.
Wree A, Eguchi A, McGeough M, Pena C, Johnson C, Canbay A . NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology. 2013; 59(3):898-910. PMC: 4008151. DOI: 10.1002/hep.26592. View

2.
Chi W, Chen H, Li F, Zhu Y, Yin W, Zhuo Y . HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation. 2015; 12:137. PMC: 4518626. DOI: 10.1186/s12974-015-0360-2. View

3.
Jin C, Flavell R . Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol. 2010; 30(5):628-31. DOI: 10.1007/s10875-010-9440-3. View

4.
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli V, Wu H . Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016; 535(7610):153-8. PMC: 5539988. DOI: 10.1038/nature18629. View

5.
Perz J, Armstrong G, Farrington L, Hutin Y, Bell B . The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4):529-38. DOI: 10.1016/j.jhep.2006.05.013. View